Fosfomycin in treatment of chronic urinary tract infection. 1975

M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela

A study was made of fosfomycin in the treatment of chronic urinary infection in 51 patients. 72% of the 67 bacteria isolated and tested in the laboratory with discs containing 50 mug of fosfomycin were found to be sensitive to the antibiotic. The majority of E. coli, Klebsiella, P. mirabilis and Ps. aeruginosa strains were sensitive to the antibiotic. Generally, 60 mg of fosfomycin/kgbody weight was administered intramuscularly 6-hourly for 7-15 days. A clinical and bacteriological cure was obtained in 39 patients (76%), and after 4-6 weeks in 31 patients (61%). Blood and urine fosfomycin levels were determined in seven patients, three with normal renal function, three with moderate renal insufficiency, and one with severe renal insufficiency. The antibiotic levels and elimination time maintained a clear relation with the degree of renal insufficiency.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
December 2018, Urologiia (Moscow, Russia : 1999),
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
March 2020, Diagnostic microbiology and infectious disease,
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
October 2019, The Medical journal of Malaysia,
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
October 2016, BMC infectious diseases,
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
January 2016, BMJ (Clinical research ed.),
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
January 1978, Infection,
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
January 2018, Urology annals,
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
November 2020, The Journal of antimicrobial chemotherapy,
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
July 1997, The Medical letter on drugs and therapeutics,
M Gobernado, and J Oleza, and M Santos, and J Roman, and M Paz, and E Mascaros, and J Almela
September 1958, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!